IMS Health acquires SaaS firm Appature

Share this article:
Kabir Shahani
Kabir Shahani

Healthcare data and analytics giant IMS Health bought Seattle-based software-as-a-service (SaaS) company Appature. Terms were not disclosed.

Clients will be able to use Appature's Nexus platform for access to both firms' services—basically data from IMS and software from Appature, whose platform lets pharma companies measure the return on relationship-marketing programs, with real-time reports and dashboards available through the cloud.

The SaaS firm will be fully owned by IMS Health but will keep its name and organizational structure. “The timing is right with the emergence of cloud technology and the willingness of our clients to adopt SaaS models,” said Barry Crowther VP, commercial effectiveness services, IMS Health.

IMS has been building its underlying marketing technology, IMS One, and Appature rounds out its marketing app suite nicely, Crowther said. “We're making substantial investments in cloud technology and SaaS models.”

Kabir Shahani, Appature co-founder and CEO, will report to Seyed Mortazavi, president, US, IMS. Having the two organizations come together “will be a huge boon to all our customers and partners,” said Shahani, adding that the combination “can help customers react…in a more real-time fashion.”

By giving clients direct access to insights 24/7, Crowther said he  hopes the purchase gives IMS a leg up in the insight-driven marketing space. “We'll be looking to apply this technology throughout the world.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.